Please enable JS

Popsi Cube

Pan European Clinical Contract Research Organisation (CRO), that offers to their partners a complete outsourcing of their clinical trials from phase I to phase IV by integrating the value creation chain of medical product development activity.

The origin of Popsi Cube is a convergence between a solid clinical process and effective IT tools. A CRO with integrated tools to address the entire clinical research functional scope. A successful project management requires top quality human resources but also a set of tools supporting a simple, pertinent and effective decision process.

 

Learn more: www.popsicube.com

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

DMEA 2024 – Berlin

March 29, 2024

April 10 & 11, 2024 Telemedicine Technologies and OVHcloud are partnering to host health data collected in hospitals for medical research studies using the CleanWeb™ software suite. This collaboration allows Telemedicine Technologies to benefit from OVHcloud’s support, including 24/7 assistance and guarantees such as data localisation in France and transparency in data processing practices. DMEA […]

READ MORE
telemedecine technologies news

Improving Diversity in Clinical Trials

March 29, 2024

Applied Clinical Trials Online A lack of diversity in clinical trials is a critical issue, as racial and ethnic subgroups may respond differently to therapies, potentially undermining efficacy and safety outcomes and producing results that are not representative of the patients who will receive the treatment in the real world. Furthermore, clinical trials provide access […]

READ MORE
telemedecine technologies news

Innovation package: METAglut1 is reimbursed under common law

March 29, 2024

Mind health The startup Metafora Biosystems, which develops a platform for cellular metabolism analysis, announced on March 11th the reimbursement approval in France for its METAglut1 test, aiding in the diagnosis of Glut1 transporter deficiency syndrome since February 15th. This blood-based test is less invasive than the previously preferred lumbar puncture. It’s the first healthcare […]

READ MORE